Home
    Disclaimer
    MMDA molecular structure

    MMDA Stats & Data

    NPS DataHub
    MW209.25
    FormulaC11H15NO3
    CAS13674-05-0
    IUPAC1-(7-Methoxy-1,3-benzodioxol-5-yl)propan-2-amine
    SMILESCOc1cc(CC(C)N)cc2OCOc12
    InChIKeyYQYUWUKDEVZFDB-UHFFFAOYSA-N
    Phenethylamines; 2020/1. Von 2-Phenethylamin abgeleitete Verbindungen; 2021/1. Von 2-Phenethylamin abgeleitete Verbindungen; 2022/1. Von 2-Phenethylamin abgeleitete Verbindungen
    Psychoactive Class Stimulant

    Pharmacology

    DrugBank
    State Solid

    Description

    MMDA, or 3-methoxy-4,5-methylenedioxyamphetamine, is a member of the amphetamine drug class with stimulant and psychedelic properties. It also acts as an entheogen and an entactogen. MMDA bears resemblance to the psychopharmacologically active essential oils elemicin and myristicin found in nutmeg. The effects of MMDA includes feelings of euphoria and warmth, as well as realistic closed-eye visuals.

    Mechanism of Action

    The mechanism that produces the psychedelic activity of MMDA has not been definitively established. There are, as of the present time, no reported studies on the human pharmacokinetics or metabolism of MMDA. Based on its structural relationship with other similar drugs for which the pharmacology is known, it is likely that MMDA has multiple mechanisms of action, and probably acts both as a 5HT2A agonist in a similar manner to hallucinogenic amphetamines such as DOM, and also as a serotonin releaser by reversing the direction of the serotonin reuptake transporter in a similar manner to MDMA.

    Indication

    MMDA is a recreational drug. It has no current medical uses and is a Schedule I controlled substance in the USA at present.

    Effect Profile

    Curated + 5 Reports
    Stimulant 6.5

    Strong euphoria and anxiety/jitters with moderate focus and stimulation

    Stimulation / Energy×3
    6
    Euphoria / Mood Lift×2
    10
    Focus / Productivity×2
    7
    Anxiety / Jitters×1
    10

    Tolerance & Pharmacokinetics

    drugs.wiki

    Tolerance Decay

    Full tolerance 1d Half tolerance 10d Baseline ~18d

    Experience Report Analysis

    Erowid
    5 Reports
    2010–2023 Date Range
    3 With Age Data
    14 Effects Detected

    Demographics

    Gender Distribution

    Age Distribution

    Reports Over Time

    Effect Analysis

    Erowid

    Effects aggregated from 5 experience reports (5 Erowid)

    5 Reports
    14 Effects Detected
    7 Positive
    3 Adverse
    4 Neutral

    Effect Sentiment Distribution

    Confidence Distribution

    Positive Effects 7

    Color Enhancement 100.0% 70%
    Euphoria 80.0% 70%
    Introspection 80.0% 70%
    Empathy 80.0% 70%
    Music Enhancement 80.0% 70%
    Focus Enhancement 60.0% 70%
    Stimulation 60.0% 70%

    Adverse Effects 3

    Anxiety 80.0% 70%
    Confusion 60.0% 70%
    Nausea 60.0% 70%

    Form / Preparation

    Most common forms and preparations reported

    ← Back to MMDA